Spruce Biosciences Inc (SPRB)
0.747
-0.02
(-2.97%)
USD |
NASDAQ |
May 17, 16:00
0.747
0.00 (0.00%)
After-Hours: 20:00
Spruce Biosciences Price to Book Value: 0.4633 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.4633 |
| May 16, 2024 | 0.4756 |
| May 15, 2024 | 0.4942 |
| May 14, 2024 | 0.5095 |
| May 13, 2024 | 0.4973 |
| May 10, 2024 | 0.5144 |
| May 09, 2024 | 0.5179 |
| May 08, 2024 | 0.5223 |
| May 07, 2024 | 0.4939 |
| May 06, 2024 | 0.4659 |
| May 03, 2024 | 0.4598 |
| May 02, 2024 | 0.4581 |
| May 01, 2024 | 0.4432 |
| April 30, 2024 | 0.4373 |
| April 29, 2024 | 0.4386 |
| April 26, 2024 | 0.4324 |
| April 25, 2024 | 0.433 |
| April 24, 2024 | 0.4335 |
| April 23, 2024 | 0.4331 |
| April 22, 2024 | 0.4275 |
| April 19, 2024 | 0.4326 |
| April 18, 2024 | 0.433 |
| April 17, 2024 | 0.4362 |
| April 16, 2024 | 0.4325 |
| April 15, 2024 | 0.4359 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.4548 |
| April 11, 2024 | 0.4716 |
| April 10, 2024 | 0.4632 |
| April 09, 2024 | 0.4746 |
| April 08, 2024 | 0.488 |
| April 05, 2024 | 0.5189 |
| April 04, 2024 | 0.5185 |
| April 03, 2024 | 0.5088 |
| April 02, 2024 | 0.5244 |
| April 01, 2024 | 0.5064 |
| March 31, 2024 | |
| March 28, 2024 | 0.4227 |
| March 27, 2024 | 0.398 |
| March 26, 2024 | 0.3765 |
| March 25, 2024 | 0.3878 |
| March 22, 2024 | 0.3926 |
| March 21, 2024 | 0.4063 |
| March 20, 2024 | 0.4006 |
| March 19, 2024 | 0.4026 |
| March 18, 2024 | 0.4082 |
| March 15, 2024 | 0.4346 |
| March 14, 2024 | 0.436 |
| March 13, 2024 | 2.783 |
| March 12, 2024 | 2.660 |
| March 11, 2024 | 2.746 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2962
Minimum
Dec 13 2022
4.015
Maximum
Mar 12 2021
1.126
Average
0.8538
Median
Jun 01 2023
Price to Book Value Benchmarks
| Vanda Pharmaceuticals Inc | 0.5863 |
| ADMA Biologics Inc | 13.89 |
| Coherus BioSciences Inc | -- |
| TRACON Pharmaceuticals Inc | -- |
| Entero Therapeutics Inc | 1.675 |
Price to Book Value Related Metrics
| PS Ratio | 3.020 |
| Price | 0.747 |
| Earnings Yield | -150.7% |
| Market Cap | 30.87M |